These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35848797)

  • 1. Analysis of free concentrations of lamotrigine and active oxcarbazepine metabolite in clinical patients by hollow-fiber centrifugal ultrafiltration.
    Dong WC; Jiang XH; Xu L; Wang H; Ni XY; Zhang ZQ; Guo JL; Jiang Y
    Bioanalysis; 2022 Jun; 14(11):795-806. PubMed ID: 35848797
    [No Abstract]   [Full Text] [Related]  

  • 2. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis.
    Lin WW; Wang CL; Jiao Z; Yu XL; Zhang J; Zhang WB; Lin RF; Lin S; Lin XH
    Ther Drug Monit; 2019 Oct; 41(5):665-673. PubMed ID: 31033858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an innovative UPLC method to quantify lacosamide, oxcarbazepine, and lamotrigine in the serum of children with epilepsy in China.
    Zhao T; Yu LH; Wang TT; Feng J; Ma L; Yu J; Sun L; Li HJ; Sun Y
    Biomed Chromatogr; 2021 Apr; 35(4):e5022. PubMed ID: 33169403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva and serum concentration of lamotrigine in patients with epilepsy.
    Tsiropoulos I; Kristensen O; Klitgaard NA
    Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine.
    Ferreira A; Rodrigues M; Oliveira P; Francisco J; Fortuna A; Rosado L; Rosado P; Falcão A; Alves G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():20-9. PubMed ID: 25261836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltration technique for the determination of plasma protein binding of three coumarins using acetone as protein binding releasing agent.
    Li J; Shi Q; Jiang Y; Liu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():114-23. PubMed ID: 26276065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.
    Contin M; Balboni M; Callegati E; Candela C; Albani F; Riva R; Baruzzi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):113-7. PubMed ID: 16182617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T; Sorri A; Moilanen E; Ylitalo P
    Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
    Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
    Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Concurrent Measurement of Gabapentin, Lamotrigine, Levetiracetam, Monohydroxy Derivative of Oxcarbazepine, and Zonisamide Concentrations in Serum in a Clinical Setting.
    Palte MJ; Basu SS; Dahlin JL; Gencheva R; Mason D; Jarolim P; Petrides AK
    Ther Drug Monit; 2018 Aug; 40(4):469-476. PubMed ID: 29994986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
    Wegner I; Wilhelm AJ; Sander JW; Lindhout D
    Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state.
    Cardot JM; Degen P; Flesch G; Menge P; Dieterle W
    Biopharm Drug Dispos; 1995 Oct; 16(7):603-14. PubMed ID: 8785383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
    Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
    Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does oxcarbazepine warrant therapeutic drug monitoring? A critical review.
    Bring P; Ensom MH
    Clin Pharmacokinet; 2008; 47(12):767-78. PubMed ID: 19026033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the clinical pharmacokinetics of oxcarbazepine.
    Flesch G
    Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The establish of the HPLC method to examine the plasma concentration of lamotrigine and oxcarbazepine.
    Zhu XP; Zhao YD; Cheng Z; Zhao NM; Li H
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1121-5. PubMed ID: 26051734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.